WuXi Biologics (Cayman) Inc DCF Valuation - WuXi Biologics (Cayman) Inc - Alpha Spread

Watchlist Manager

Watchlist

Price: 44.94 HKD -9.03% Market Closed

Market Cap: HK$186.2B

DCF Value

The DCF Value for WuXi Biologics (Cayman) Inc (2269) under the Base Case is hidden HKD. Compared with the current market price of 44.94 HKD, the stock appears hidden .

Key assumptions

WuXi Biologics (Cayman) Inc DCF Value

Unlock

DCF Assumptions

Revenue Growth 9.2%

Net Margin 24%22.3%

Cash Flow Conversion 88%

Forecast Period 10 years

Model Settings

Template via FCFE

Discount Rate 6%

Exit Multiple 3.7x P/S

Valuation Result

·

Reverse DCF

Continue Research

Relative Valuation

Wall St Estimates

Financial Statements

Join 361,800+ value investors using Alpha Spread

Create Free Account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.